Omission of evidence from review on prophylaxis of fungal infections
First published: 14 March 2007
Sue Richards, CTSU, Oxford University, Oxford OX3 7LF, UK; Tel.: +44 1865 743 863; Fax: +44 1865 743 986;e-mail:
[email protected] No abstract is available for this article.
References
- 1
Maertens J.
Evaluating prophylaxis of invasive fungal infections in patients with hematologic malignancies.
Eur J Haematol
2007; 78: 275–82.
- 2
Gøtzsche PC,
Johansen HK.
Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Cochrane Database Syst Rev
2002:CD000026. doi: 10.1002/14651858.CD000026.
- 3
Gøtzsche PC,
Johansen HK.
Misleading statements in industry-sponsored meta-analysis of itraconazole.
J Clin Oncol
2005; 23: 9428–9.
